Merck stock (NYSE: MRK) lost about 10% in 2024, underperforming the broader S&P 500 index, which gained 23% for the year.

<iframe src="https://www.googletagmanager.com/ns.html?id=GTM-T6GGB6V" height="0" width="0" style="display:none;visibility:hidden"></iframe> ...

“Approximately 500 people will be affected in select sales and headquarters commercial teams,” Eisele said. “The roles being eliminated are located across all states; but for administrative purposes, ...

Merck shares trade at a significant discount to peers. The company faces challenges, but there are reasons to be bullish.

Up to 100 of those job cuts will come at Merck headquarters, while the rest are to be eliminated outside of Germany by the end of 2025. The company has already reached an agreement with labour ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, will hold its fourth-quarter and full-year 2024 sales and earnings conference call with institutional investors and ...

The Merck Future Insight prize was established on the occasion of Merck’s 350th anniversary in 2018 to honour and enable pioneering scientists who are striving to solve some of the biggest ...